. Author manuscript; available in PMC: 2014 Nov 26.

Published in final edited form as: Psychopharmacology (Berl). 2011 Jun 7;219(1):15–24. doi: 10.1007/s00213-011-2374-5

Table 4.

Effects of AMP and THC on select mood and physiological measures at the time of DRM list studying

	AMP group				THC group
	Placebo	10 mg^a	20 mg^a	Dose^b (F_{2, 23})	Placebo	7.5 mg^a	15 mg^a	Dose^b (F_{2, 23})
Feel—DEQ (range 0–10)	0.32 (0.10)	0.84 (0.35)	1.88^* (0.46)	8.80	0.14 (0.06)	2.63^* (0.53)	3.53^* (0.58)	22.58
Drug Preference (range −10 to 10)	0.02 (0.16)	0.81 (0.36)	2.63^* (0.67)	12.67	−0.03 (0.04)	0.31 (0.57)	−0.91 (0.75)	1.58
Stimulated—VAS (range 0–10)	−0.89 (0.23)	−0.24 (0.36)	1.48^* (0.56)	14.62	−0.54 (0.17)	0.90^* (0.42)	0.78^* (0.49)	6.00
BP (systolic)	−5.42 (1.52)	5.64^* (0.97)	10.02^* (2.35)	18.00	−4.08 (1.25)	−1.78 (2.00)	−0.10 (1.73)	1.61
BP (diastolic)	−2.72 (1.30)	5.96^* (1.00)	12.66^* (1.54)	32.21	−2.28 (1.14)	−1.40 (1.11)	1.76^* (1.54)	4.08
HR	−9.74 (1.65)	2.86^* (1.67)	4.92^* (1.80)	26.92	−7.44 (1.84)	−3.20 (1.84)	4.46^* (2.77)	10.84

Data are change from baseline means (SEM) of ratings obtained immediately before and after DRM list studying (+120 and +150 min post-capsule). Bold values indicate a significant main effect of drug dose (p<0.05)

p <0.05

Two-tailed paired t tests—compared to placebo

Repeated measures ANOVA